1) Yamada M:Cerebral amyloid angiopathy:an overview. Neuropathology 20:8-22, 2000
2) Suzuki N, Iwatsubo T, Odaka A, et al:High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 145:452-460, 1994
3) Lippa CF, Hamos JE, Smith TW, et al:Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques or tangles. Arch Neurol 50:1088-1092, 1993
4) Yamada M, Tsukagoshi H, Otomo E, et al:Cerebral amyloid angiopathy in the aged. J Neurol 234:371-376, 1987
5) Itoh Y, Yamada M, Hayakawa M, et al:Cerebral amyloid angiopathy:a significant cause of cerebellar as well as lober cerebral hemorrhage in the elderly. J Neurol Sci 116:135-141, 1993
6) Yamada M, Itoh Y, Suematsu N, et al:Vascular variant of Alzheimer's disease characterized by severe plaque-like beta protein angiopathy. Dement Geriatr Cogn Disord 8:163-168, 1997
7) Gray F, Dubas F, Roullet E, et al:Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 18:54-59, 1985
8) Yamada M, Itoh Y, Shintaku M, et al:Immune reactions associated with cerebral amyloid angiopathy. Stroke 27:1155-1162, 1996
9) Eng JA, Frosch MP, Choi K, et al:Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55:250-256, 2004
10) Kinnecom C, Lev MH, Wendell L, et al:Course of cerebral amyloid angiopathy-related inflammation. Neurology 68:1411-1416, 2007
11) Thanvi B, Robinson T:Sporadic cerebral amyloid angiopathy-an important cause of cerebral haemorrhage in older people. Age Ageing 35:565-571, 2006
12) Mathis CA, Klunk WE, Price JC, et al:Imaging technology for neurodegenerative diseases. Progress toward detection of specific pathologies. Arch Neurol 62:196-200, 2005
13) Dubois B, Feldman HH, Jacova C, et al:Research criteria for the diagnosis of Alzheimer's disease:revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734-746, 2007
14) Johnson KA, Gregas M, Becker JA, et al:Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 62:229-234, 2007
15) Greenberg SM, Rebeck GW, Vonsattel JP, et al:Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38:254-259, 1995
16) Premkumar DR, Cohen DL, Hedera P, et al:Apolipoprotein E-ε4 in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 148:2083-2095, 1996
17) Zarow C, Zaias B, Lyness SA, et al:Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuronal loss. Alz Dis Ass Disord 13:1-8, 1999
18) McCarron MO, Nicoll JA, Ironside JW, et al:Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE ε2 with putative clinical risk factors. Stroke 30:1643-1646, 1999
19) O'Donnell HC, Rosand J, Knudsen KA, et al:Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342:240-245, 2000
20) Yamada M, Itoh Y, Suematsu N, et al:Lack of the association between apolipoprotein E and cerebral amyloid angiopathy in the elderly Japanese. Ann Neurol 39:683, 1996
21) Yamada M, Sodeyama N, Itoh Y, et al:Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke 28:2219-2221, 1997
22) Yamada M, Sodeyama N, Itoh Y, et al:Association of α1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann Neurol 44:129-131, 1998
23) Yamada M, Sodeyama N, Itoh Y, et al:Butyrylcholinesterase K variant and cerebral amyloid angiopathy. Stroke 29:2488-2490, 1998
-macroglobulin gene and cerebral amyloid angiopathy. Stroke 30:2277-2279, 1999
25) Yamada M, Sodeyama N, Itoh Y, et al:No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy. Stroke 33:896-900, 2002
26) Yamada M, Sodeyama N, Itoh Y, et al:Association of neprilysin polymorphism with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 74:749-751, 2003
27) Hamaguchi T, Okino S, Sodeyama N, et al:Association of a polymorphism of the transforming growth factor-β1 gene with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 76:696-699, 2005
28) Levy E, Carman MD, Femandez-Madred IJ, et al:Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124-1126, 1990
29) Wattendorff AR, Bots GT, Went LN, et al:Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage. J Neurol Sci 55:121-135, 1982
30) Rozemuller AJ, Roos RA, Bots GT, et al:Distribution of β/A 4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am J Pathol 142:1449-1457, 1993
31) Wattendorff AR, Frangione B, Luyendijk W, et al:Hereditary cerebral haemorrhage with amyloidosis, Dutch type(HCHWA-D):clinicopathological studies. J Neurol Neurosurg Psychiatry 58:699-705, 1995
32) Bugiani O, Padovani A, Magoni M, et al:An Italian type of HCHWA. Neurobiol Aging 19:S 238, 1998
33) Nilsberth C, Westlind-Danielsson A, Eckman CB, et al:The ‘Arctic' APP mutation(E693G)causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat Neurosci 4:887-893, 2001
34) Hendriks L, van Duijn CM, Cras P, et al:Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 β-amyloid precursor protein gene. Nat Genet 1:218-221, 1992
35) Cras P, van Harskamp F, Hendriks L, et al:Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692 Ala→Gly mutation. Acta Neuropathol 96:253-260, 1998
36) Grabowski TJ, Cho HS, Vonsaitel JP, et al:Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49:697-705, 2001
37) Farzan M, Schnitzler CE, Vasilieva N, et al:BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci USA 97:9712-9717, 2000
38) Rovelet-Lecrux A, Hannequin D, Raux G, et al:APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24-26, 2006
39) Cabrejo L, Guyant-Maréchal L, Laquerriére A, et al:Phenotype associated with APP duplication in five families. Brain 129:2966-2976, 2006
40) Sleegers K, Brouwers N, Gijselinck I, et al:APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129:2977-2983, 2006
41) Rovelet-Lecrux A, Frebourg T, Tuominen H, et al:APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 78:1158-1159, 2007
42) De Strooper B:Loss-of-function presenilin mutations in Alzheimer disease. EMBO Rep 8:141-146, 2007
43) Sherrington R, Rogaev EI, Liang Y, et al:Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760, 1995
44) Levy-Lahad E, Wasco W, Poorkaj P, et al:Candidate gene for the chromosome 1 familial Alzeheimer's disease locus. Science 269:973-977, 1995
45) Rogaev EI, Sherrington R, Rogaeva EA, et al:Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzeheimer's disease type 3 gene. Nature 376:775-778, 1995
46) Dermaut B, Kumar-Singh S, De Jonghe C, et al:Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain 124:2383-2392, 2001
I). Ann Neurol 43:131-135, 1998
48) Donahue JE, Khurana JS, Adelman LS:Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy. Acta Neuropathol 95:213-216, 1998
49) Greenberg SM, Briggs ME, Hyman BT, et al:Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27:1333-1337, 1996
50) Smith EE, Gurol ME, Eng JA, et al:White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 63:1606-1612, 2004
51) Ellis RJ, Olichney JM, Thal LJ, et al:Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease:the CERAD experience, Part XV. Neurology 46:1592-1596, 1996
52) Pfeifer M, Boncristiano S, Bondolfi L, et al:Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298:1379, 2002